CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Markets to open with negative bias

DSIJ Intelligence-3 0 1025 Article rating: 4.2

Indian markets may remain under pressure at the opening bell as negative sentiments prevailing among the global peers might affect the Indian markets. As TCS managed to post a positive top line growth despite pandemic challenges and also the management sounded bullish about the company prospects, markets might get some relief from TCS earnings and management commentary.

Domestic indices close higher than 1 per cent upon taking cues from global indices

DSIJ Intelligence 0 762 Article rating: 5.0

Markets on Thursday regained Wednesday's losses with domestic benchmark indices closing higher than their previous close. Sensex gained by 408.68 points or 1.12 per cent to settle at 36,737.69 while Nifty increased by 107.70 points or 1.01 per cent to settle at 10,813.45.

Strides Pharma climbs 3 per cent on getting US regulator nod

DSIJ Intelligence 0 918 Article rating: 5.0

In the early trading session on Thursday, the stock of Strides Pharma Science was trading in green after the company made an announcement that its wholly-owned subsidiary, Strides Pharma Global Private Limited was granted regulatory approval by United States Food and Drug Administration (USFDA) for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate capsules of 50 mg/325 mg/40 mg/30 mg.

Bank Nifty forms shooting star-like pattern; zone of 22,000-21,840 is crucial for downside

Vinayak Gangule 0 1824 Article rating: 4.5

The price action formed a long upper shadow and a small real body, which closed near the bottom end of the trading range. Meanwhile, in Japanese, the candlestick parlance is known as the shooting star pattern. The shooting star’s long upper shadow reflects the market rejection of higher prices.

Sensex cuts gaining streak; IndusInd Bank surges by 5 per cent

DSIJ Intelligence 0 987 Article rating: 5.0

In the afternoon trading session on Wednesday, benchmark indices witnessed a sharp decline resulting from sudden selling in domestic markets. Sensex shed nearly 500 points from the day's high to close at 36,329.01 that is 345.51 points or 0.94 per cent lower than its previous close while Nifty fell by 93.90 points or by 0.87 per cent to close at the level of 10,705.75.

Steel Strips Wheels Ltd jumps seven per cent

Nidhi Jani 0 1685 Article rating: 4.6

It has also received another order worth US$ 1,40,000 from the US and EU markets, which involves the supply of nearly 3,100 commercial vehicles (CV) wheels for the US and EU markets. This order win would drive the revenue as the company enjoys around 52 per cent market share in the medium and heavy commercial vehicle (M&HCV) segment.

PVR sets Rs 784 as rights issue price

Nidhi Jani 0 2165 Article rating: 4.2

Taking measures to enhance the company's liquidity, the board of directors has authorised a rights issue of Rs 300 crore. The company has set the price for the rights issue at Rs 784 per share (almost at 25 per cent discount from its previous close of Rs 1,043.40), which includes a premium of Rs 774 per share, over the face value of Rs 10 per share.

Sensex gains by over 1 per cent; RIL, HDFC Bank and TCS are top index contributors

DSIJ Intelligence 0 1361 Article rating: 4.8

Continuing gains for the fourth consecutive trading session, domestic benchmark indices closed with Sensex at 36,487.28 that is 456.86 points or 1.29 per cent higher than its previous close while Nifty rose by 156.30 points or 1.47 per cent to close at 10,763.65.

API business opportunities push Aarti Drugs; stock zooms 132 per cent in 6 months

Nidhi Jani 0 4260 Article rating: 4.2

Currently, India imports over 60 per cent of its APIs consumption from China and other countries, which opens up significant opportunities for Indian API manufacturers like Aarti Drugs. The company has geared up its API production by nearly 44 per cent to 25,591 MT in FY20.

Granules recall twelve lots of Metformin Hydrochloride ER tablets

DSIJ Intelligence 0 1866 Article rating: 4.9

Granules Pharmaceuticals, Inc., (Chantilly, Virginia), which is a wholly-owned subsidiary of Granules India Limited, has voluntarily recalled 12 lots of Metformin Hydrochloride extended-release tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of N-Nitrosodimethylamine (NDMA) levels above the acceptable daily intake (ADI).

Balaji Amines jumps seven per cent owing to developing expansion plans

Pratik Shastri 0 1802 Article rating: 4.0

Moreover, prospective growth triggers are likely for its agrochemical business. Various factors are at play for this such as the storage levels in water reservoirs across the country, a hike in minimum support price (MSP) of key Kharif crops and an anticipated strong monsoon spread.

RSS
First340341342343345347348349Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR